Cargando…
Reply to: “Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19”
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443101/ https://www.ncbi.nlm.nih.gov/pubmed/32855991 http://dx.doi.org/10.1093/ofid/ofaa321 |
| _version_ | 1783573567264260096 |
|---|---|
| author | Nicolini, Laura Ambra Mikulska, Malgorzata Signori, Alessio Di Biagio, Antonio Portunato, Federica Vena, Antonio Giacomini, Mauro Bassetti, Matteo |
| author_facet | Nicolini, Laura Ambra Mikulska, Malgorzata Signori, Alessio Di Biagio, Antonio Portunato, Federica Vena, Antonio Giacomini, Mauro Bassetti, Matteo |
| author_sort | Nicolini, Laura Ambra |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7443101 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74431012020-08-26 Reply to: “Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19” Nicolini, Laura Ambra Mikulska, Malgorzata Signori, Alessio Di Biagio, Antonio Portunato, Federica Vena, Antonio Giacomini, Mauro Bassetti, Matteo Open Forum Infect Dis Correspondence Oxford University Press 2020-07-29 /pmc/articles/PMC7443101/ /pubmed/32855991 http://dx.doi.org/10.1093/ofid/ofaa321 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Correspondence Nicolini, Laura Ambra Mikulska, Malgorzata Signori, Alessio Di Biagio, Antonio Portunato, Federica Vena, Antonio Giacomini, Mauro Bassetti, Matteo Reply to: “Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19” |
| title | Reply to: “Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19” |
| title_full | Reply to: “Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19” |
| title_fullStr | Reply to: “Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19” |
| title_full_unstemmed | Reply to: “Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19” |
| title_short | Reply to: “Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19” |
| title_sort | reply to: “antiviral activity and safety of darunavir/cobicistat for treatment of covid-19” |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443101/ https://www.ncbi.nlm.nih.gov/pubmed/32855991 http://dx.doi.org/10.1093/ofid/ofaa321 |
| work_keys_str_mv | AT nicolinilauraambra replytoantiviralactivityandsafetyofdarunavircobicistatfortreatmentofcovid19 AT mikulskamalgorzata replytoantiviralactivityandsafetyofdarunavircobicistatfortreatmentofcovid19 AT signorialessio replytoantiviralactivityandsafetyofdarunavircobicistatfortreatmentofcovid19 AT dibiagioantonio replytoantiviralactivityandsafetyofdarunavircobicistatfortreatmentofcovid19 AT portunatofederica replytoantiviralactivityandsafetyofdarunavircobicistatfortreatmentofcovid19 AT venaantonio replytoantiviralactivityandsafetyofdarunavircobicistatfortreatmentofcovid19 AT giacominimauro replytoantiviralactivityandsafetyofdarunavircobicistatfortreatmentofcovid19 AT bassettimatteo replytoantiviralactivityandsafetyofdarunavircobicistatfortreatmentofcovid19 |